VETFLURANE 1000 MG/G INHALATION VAPOUR, LIQUID
Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Preparatomtale
(SPC)
12-03-2016
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
ISOFLURANE
Tilgjengelig fra:
Virbac S.A.
ATC-kode:
QN01AB06
INN (International Name):
ISOFLURANE
Dosering :
1000 mg/g
Legemiddelform:
Inhalation Vapour Liquid
Resept typen:
VPO-Vet.Practitioner Only
Terapeutisk gruppe:
Avian, Canine, Equine - Food, Feline, Ferret, Gerbils, Guinea Pigs, Hamsters, Non Food Animals, Reptile
Terapeutisk område:
Isoflurane
Indikasjoner:
Neurological Preparations
Autorisasjon status:
Authorised
Autorisasjon dato:
2010-09-24
Preparatomtale
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetflurane 1000 mg/g Inhalation vapour, liquid
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each millilitre contains:
Active substance:
Isoflurane 1000 mg/g.
The veterinary medicinal product contains no excipients.
3 PHARMACEUTICAL FORM
Inhalation vapour, liquid.
Clear, colourless liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
4.3 CONTRAINDICATIONS
Do not use in case of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to isoflurane or to other halogenated agents.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The metabolism of birds, and to an extent small mammals, is affected more profoundly by decreases in body
temperature, due to high surface area to body weight ratio. Drug metabolism in reptiles is slow and highly dependent
upon environmental temperature.
The absorption, distribution and elimination of isoflurane are rapid, and it is eliminated largely unchanged via the
lungs. These characteristics may make it suitable for groups of patients including the young or old, or those with
impaired hepatic, renal or cardiac function, however anaesthetic protocols should be decided on a case by case basis.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 19/02/2016_
_CRN 7019457_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Isoflurane has little or no analgesic properties. Adequate analgesia should always be given
Les hele dokumentet
